PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.

Cite this paper

@article{Chen2004PKC412IT, title={PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.}, author={Jing Chen and Daniel J. Deangelo and Jeffery L. Kutok and Ifor R Williams and Benjamin Hoyoung Lee and Martha Wadleigh and Nicole Duclos and Sarah Cohen and Jennifer Adelsperger and Rachel O. Okabe and Allison Coburn and Ilene A. Galinsky and Brian J P Huntly and Pamela Schwartz Cohen and Thomas Meyer and Doriano Fabbro and Johannes L. Roesel and Lolita Banerji and James D Griffin and Sheng Xiao and Jonathan Alfred Fletcher and Richard M Stone and Dwight Gary Gilliland}, journal={Proceedings of the National Academy of Sciences of the United States of America}, year={2004}, volume={101 40}, pages={14479-84} }